Mind Medicine (NASDAQ: MNMD)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-19 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.040 | 0.0100 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Mind Medicine (NASDAQ: MNMD) through any online brokerage.
There are no as such competitors for Mind Medicine.
The latest price target for Mind Medicine (NASDAQ: MNMD) was reported by Roth Capital on Wednesday, May 4, 2022. The analyst firm set a price target for 7.00 expecting MNMD to rise to within 12 months (a possible 1035.07% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Mind Medicine (NASDAQ: MNMD) is $0.6167 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Mind Medicine.
Mind Medicine’s Q2 earnings are confirmed for Friday, August 19, 2022.
The stock split for MNMD was announced on Thursday, August 4, 2022. The date this stock split will start trading, also known as the ex-date, will be on Monday, August 29, 2022.
Mind Medicine is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.